Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-12-11-Speech-2-161"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20071211.32.2-161"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"The Innovative Medicines Initiative is a unique initiative instigated by the European Commission and the European Federation of Pharmaceutical Industries and Associations, which will have a budget of EUR 2 billion to 2013. That is why I also voted in favour of the report.
I am convinced that this partnership between the private and public sectors will help to speed up the distribution of better and safer medicines.
I am happy that the Innovative Medicines Initiative will improve research conditions and with them the chances of developing better medicines for the treatment of neglected diseases.
Secondly, as a member of the small and medium-sized enterprises association I am thrilled with this first public-private partnership, which includes funding for cooperation between small and medium-size enterprises, universities, research centres, academies and associations, which are members of the EFPIA.
This method of financing will at last provide access to the required resources and thereby create a favourable environment for research in the European Union and increase its competitiveness. Our Member States should expect results...."@en1
|
lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples